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Abstract
Introduction Sex-difference in types of cardiac organ damage has been reported in subjects with increased body mass 
index (BMI). However less is known about sex-differences in left ventricular (LV) myocardial function assessed by global 
longitudinal strain (GLS) in these subjects.
Methods 493 subjects (mean age 47 ± 9 years, 61% women) with BMI > 27.0 kg/m2 and without known cardiac disease 
underwent 24-hour (24h) ambulatory blood pressure (BP) recording, body composition analysis, carotid-femoral pulse wave 
velocity (PWV) measurement and echocardiography. LV peak systolic GLS was measured by two-dimensional speckle 
tracking echocardiography and LV ejection fraction (EF) by biplane Simpson’s method. Insulin sensitivity was assessed by 
homeostatic model of insulin resistance (HOMA-IR).
Results Women had higher prevalence of increased waist circumference (99% vs. 82%), lower prevalence of hyperten-
sion (59 vs. 74%), and lower serum triglycerides (1.3 ± 0.7 vs. 1.7 ± 0.9 mmol/L) and carotid-femoral PWV (7.3 ± 1.6 vs. 
7.7 ± 1.6 m/s) compared to men (all p < 0.05). Women also had higher (more negative) GLS compared to men (− 19.9 ± 3.0 
vs. − 18.6 ± 3.0%, p < 0.001), while EF did not differ between sexes. In multivariable linear regression analyses, lower GLS 
in women was associated with higher waist circumference and PWV and with lower EF (all p < 0.05). In men, lower GLS 
was associated with higher waist circumference and HOMA-IR, and with lower EF (all p < 0.05).
Conclusions Among subjects with increased BMI, GLS was higher in women than men. Lower GLS was associated with 
abdominal obesity in both sexes, and with impaired glucose metabolism in men, and with higher arterial stiffness in women.
Trial registration https ://www.clini caltr ials.gov NCT02805478, first registered 20.06.16.
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1 Introduction
The obesity epidemic has resulted in an increasing preva-
lence of cardiometabolic disorders both in women and men 
[1, 2]. Underlying mechanisms include obesity-associated 
left ventricular (LV) volume and pressure overload, chronic 
inflammation and clustering of cardiovascular risk factors 
like hypertension, impaired glucose metabolism and dys-
lipidemia [3–5]. Previous studies in subjects with increased 
body mass index (BMI) have demonstrated that although 
systolic LV function measured by ejection fraction (EF) 
often is normal, myocardial function assessed by global 
longitudinal strain (GLS) or stress-corrected midwall short-
ening is often reduced [4, 6–8]. This has been attributed to 
interstitial fat infiltration and triglyceride accumulation in 
the contractile elements in the obese heart, affecting both 
LV mass, systolic function and myocardial energetic effi-
ciency [9, 10]. Recently, an association between increased 
epicardial adipose tissue, higher myocardial fat content and 
reduced LV GLS was published [11].
Sex differences in prevalence and type of subclinical 
cardiac disease in subjects with increased BMI have previ-
ously been reported [3, 12]. Both in healthy subjects and 
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in patients with hypertension, previous studies have found 
lower LV GLS in men than women [13, 14]. The Hyperten-
sion Genetic Epidemiology Network study found that higher 
waist circumference and waist-hip ratio was associated with 
lower LV GLS, but did not report sex-specific results [15]. 
Taken together, these results indicate that LV GLS is lower 
in subjects with increased BMI, but sex specific confounders 
of LV GLS are not well documented. Thus, the aim of the 
current study was to explore LV GLS and its covariates in 
women and men with increased BMI.
2  Methods
2.1  Study Population
A total of 620 women and men between 30 and 65 years of 
age, with BMI > 27.0 kg/m2 were prospectively recruited to 
the FAT associated CardiOvasculaR dysfunction (FATCOR) 
study at Haukeland University Hospital in Bergen, Norway, 
between 2009 and 2017. In the present analysis, a total of 
127 participants were excluded due to incomplete echocardi-
ographic data (n = 51), insufficient echocardiographic image 
quality (n = 49), hardware mismatch (n = 25) and withdrawal 
of consent (n = 2). Details about methods used in the FAT-
COR study have been published previously [3, 16–18]. In 
short, recruitment of participants was done in collaboration 
with a primary health care center with particular interest 
in management of obesity. Most subjects were recruited 
through a local newspaper advertisement. Exclusion crite-
ria in the FATCOR study were previous myocardial infarc-
tion, gastrointestinal disorders, severe psychiatric illness or 
inability to understand Norwegian language. The included 
group was older than the excluded group (49.7 ± 8.9 vs. 
47.3 ± 9.2 years, p < 0.01), while sex, BMI, or prevalence of 
hypertension and diabetes mellitus did not differ between the 
included and the excluded groups. The FATCOR study was 
conducted in accordance with the Declaration of Helsinki 
from 1975 and was approved by the Regional Ethics Com-
mittee. All participants signed a written informed consent 
form.
2.2  Cardiovascular Risk Assessment
All study participants underwent a standardized clinical 
examination at the general practitioner center. A standard-
ized questionnaire was used for self-reported health and use 
of medication. This information was quality assured by a 
study nurse.
Tetrapolar bioelectrical impedance analysis (Tatina-TBF-
300A, Tanita Corporation of America, Arlington Heights, 
USA) was used to analyze body composition including total 
body weight, BMI, fat and muscle mass. Obesity was con-
sidered present if BMI ≥ 30.0 kg/m2 [19].
Clinic blood pressure (BP) was measured with an Omron 
M4 sphygmomanometer (Omron Healthcare Co. Ltd., Hoof-
dorp, Netherlands) using a correctly sized cuff in the indi-
vidual participant. Attended clinic BP was measured in tri-
plets after 5 minutes initial rest in seated position with 1-min 
intervals between the measurements [20]. The average of the 
two last BP measurements was taken as the clinic BP.
Ambulatory 24-hour (24h) BP (24hBP) recording was 
performed with a correctly sized cuff on the non-dominant 
arm in the individual participant, using Diasys Integra II 
recorders (Novacor, Cedex, France). Measurements were 
done with 20 min interval during daytime and 30 min inter-
val during nighttime. Participants were instructed to follow 
their daily routine during the recording and relax the arm 
during cuff expansion. Hypertension was considered pre-
sent if participants used anti-hypertensive medication or had 
elevated 24hBP (24h systolic BP ≥ 130 mmHg and/or 24h 
diastolic BP ≥ 80 mmHg).
Serum lipid profile was measured in fasting venous blood 
samples [16]. A standardized 2-h oral glucose tolerance test 
was performed in participants without previously diag-
nosed diabetes mellitus. Diabetes mellitus was considered 
present if any of the following factors were present in the 
individual participant: history of diabetes, fasting plasma 
glucose ≥ 7.0 mmol/L, glycated hemoglobin  A1c  (HbA1c) 
≥ 6.5% or a 2-h plasma glucose ≥ 11.1 mmol/L after oral 
glucose tolerance test [21]. The homeostatic model of insu-
lin resistance (HOMA-IR) was calculated as the product of 
fasting plasma insulin and glucose divided by 22.5 [22]. 
The metabolic syndrome (MetS) was considered present 
if any 3 of the 5 following criteria were met in the indi-
vidual participant: increased waist circumference (≥ 102 cm 
in men, ≥ 88 cm in women), elevated serum triglycerides 
(TG) (≥ 1.7  mmol/L), reduced serum HDL cholesterol 
(<  1.03 mmol/L in men, <  1.3 mmol/L in women), elevated 
BP (≥ 130 mmHg systolic and/or ≥ 85 mmHg diastolic BP 
or the use of antihypertensive treatment), and elevated fast-
ing glucose (≥ 5.6 mmol/L) or drug treatment for elevated 
glucose [23].
2.3  Arterial Stiffness Assessment
Applanation tonometry (SphygmoCor, AtCor Medical, Syd-
ney, West Ryde, Australia) was used to measure carotid-
femoral pulse wave velocity (PWV). A PWV > 10 m/s was 
considered increased [20].
2.4  Conventional Echocardiography
A transthoracic two-dimensional (2D) echocardiogram 
was performed following a standardized imaging protocol 
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on a Vivid E9 echocardiograph (GE Vingmed Ultrasound, 
Horten, Norway) as previously described [3]. The echo-
cardiographic images were digitally stored and post-pro-
cessed offline in the Echocardiography Core Laboratory 
at the University of Bergen, Norway using Image Arena 
software version 4.6 (TomTec Imaging Systems GmbH, 
Unterschleissheim, Germany). Quantitative echocardio-
graphic analyses were performed in accordance with cur-
rent guidelines for chamber quantification [24]. Relative 
wall thickness was calculated from posterior wall thick-
ness/LV internal radius ratio and considered increased if 
≥ 0.43 [20, 25]. LV mass was calculated using Devereux’s 
formula and indexed for body height in the allometric 
power of 2.7. LV hypertrophy was defined by the prognos-
tically validated cut-off values; LV mass index > 46.7 g/
m2.7 in women and > 49.2 g/m2.7 in men, respectively [24, 
26]. LV EF was calculated by the biplane Simpson method 
[24]. All conventional image analyses were proof read by 
a single expert reader (EG) as recommended for clinical 
trials [27].
2.5  Speckle Tracking Echocardiography
Analysis was performed by a single junior reader (NP) 
on a workstation equipped with EchoPAC version BT202 
software (GE Vingmed Ultrasound, Horten, Norway) and 
quality assured by a single experienced reader (SS). Peak 
systolic LV GLS was measured by Automated Function 
Imaging in each LV segment using an 18-segment model 
and apical 4-, 2- and 3-chamber views. The region of inter-
est (ROI) was automatically generated based on three man-
ual points set by the reader. To include the myocardium 
and avoid the pericardium or optimize tracking, the reader 
manually adjusted the ROI when necessary.
2.6  Statistical Analysis
Statistical analyses were performed using the IBM SPSS 
Statistics software version 25 (IBM, Armonk, New York, 
USA). The cohort was split by sex. For the descrip-
tive analyses, continuous variables were presented as 
mean ± standard deviation and categorical variables as 
percentages. Uni- and multivariable linear regression 
analyses with collinearity tools were used to identify the 
covariables of LV GLS. Results are reported as standard-
ized beta coefficients and p-values. Inter-observer repro-
ducibility of LV GLS was evaluated by reanalysis of 26 
randomly selected study participants and reported as inter-
class correlation coefficient and 95% confidence interval 
(CI). A p-value < 0.05 was considered statistically signifi-
cant in all analyses.
3  Results
The total study population was on average 47 ± 9 years, 
included 61% women, and the mean BMI was 
32.1 ± 4.2  kg/m2. Women had higher BMI and higher 
prevalence of increased waist circumference, but lower 
prevalence of hypertension, serum TG and blood glucose 
compared to men (all p < 0.05), while HOMA-IR and the 
prevalence of diabetes mellitus did not differ between 
sexes (Table 1). Although LV EF did not differ between 
sexes, average LV GLS was significantly lower in men 
than women (p < 0.001) (Table 2).
The inter-observer reproducibility of GLS was excel-
lent with interclass correlation coefficient 0.96 [95% CI 
0.95–0.98]. In the total study population, lower LV GLS 
was independently associated with male sex both in uni-
variable (β = 0.21) and multivariable analyses (β = 0.25) 
(both p < 0.05). In women, lower LV GLS was signifi-
cantly associated with higher waist circumference, serum 
TG, HOMA-IR, PWV and hypertension in univariable 
analyses (all p < 0.05) (Table 3). In multivariable linear 
regression analysis, lower LV GLS remained associated 
with higher waist circumference and PWV and with lower 
LV EF in women (all p < 0.05) (Table 3). In men, lower 
LV GLS was associated with higher HOMA-IR and waist 
circumference and with lower LV EF analysis both in uni- 
and multivariable linear regression analysis (all p < 0.05) 
(Table 3).
There was an inversed, linear correlation between GLS 
and serum triglyceride in women, r = 0.15, p = 0.010, but 
not in men (Fig. 1a). However, the negative, linear cor-
relation between GLS and C-peptide was stronger in men 
than women, r = 0.28, p = 0.001 and r = 0.16, p = 0.006 
(Fig. 1b).
4  Discussion
The present study assessed the impact of sex on LV 
myocardial function measured by GLS in subjects with 
increased BMI and without known cardiovascular disease. 
In particular, the results demonstrate that: (1) women with 
increased BMI had higher LV GLS than men despite a 
comparable LV EF, (2) lower LV GLS was associated 
with male sex independent of higher PWV, HOMA-IR 
and waist circumference in the total study population, and 
(3) in sex-specific analyses, lower LV GLS was associated 
with higher waist circumference in both sexes, and par-
ticularly with higher HOMA-IR in men, and with higher 
arterial stiffness in women.
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Sex differences in body fatness and fat distribution are 
well known [28]. While men are more prone to abdomi-
nal fat deposition around the internal organs, referred 
to as visceral obesity, women preferentially store fat 
subcutaneously in the gluteofemoral region [29]. Visceral 
obesity leads to insulin resistance and chronic low-grade 
systemic inflammation, contributing to development 
of preclinical and clinical cardiovascular disease [30]. 
Table 1  Characteristics of 
the total study population and 
groups of women and men
HDL high-density-lipoprotein, LDL low-density-lipoprotein, 24h 24  hour, BP blood pressure, BMI body 
mass index, HbA1c glycated hemoglobin, HOMA-IR homeostatic model of insulin resistance
Variable Total study popu-
lation (n = 493)
Women (n = 301) Men (n = 192) P
Age (years) 47 ± 9 48 ± 9 47 ± 9 0.362
Height (cm) 172.4 ± 9.1 167.2 ± 6.1 180.6 ± 6.8 < 0.001
Weight (kg) 95.4 ± 15.9 90.5 ± 14.7 103.0 ± 14.6 < 0.001
Waist circumference (cm) 108 ± 11 106 ± 12 110 ± 10 < 0.001
Increased waist circumference (%) 92 99 82 < 0.001
BMI (kg/m2) 32.1 ± 4.2 32.4 ± 4.4 31.6 ± 3.8 0.038
Obesity (%) 62.5 63.1 61.5 0.710
Total fat percentage (%) 37.6 ± 8.3 42.8 ± 4.6 29.4 ± 5.6 < 0.001
Muscle mass (kg) 56.3 ± 11.9 48.6 ± 5.6 68.2 ± 9.1 < 0.001
Blood glucose (mmol/L) 5.3 ± 0.9 5.2 ± 0.73 5.5 ± 1.1 0.001
HbA1c (%) 5.6 ± 0.5 5.6 ± 0.5 5.6 ± 0.6 0.943
HOMA-IR 3.5 ± 4.8 3.3 ± 3.7 3.9 ± 6.3 0.237
Diabetes mellitus (%) 10.2 9.6 11.2 0.584
Pulse wave velocity (m/s) 7.5 ± 1.6 7.3 ± 1.6 7.7 ± 1.6 0.003
Clinic systolic BP (mmHg) 130 ± 17 127 ± 17 134 ± 14 < 0.001
Clinic diastolic BP (mmHg) 82 ± 9 80 ± 9 85 ± 10 < 0.001
Clinic heart rate at rest (beats/min) 68 ± 10 69 ± 10 65 ± 11 < 0.001
24h systolic BP (mmHg) 121 ± 13 119 ± 12 125 ± 12 < 0.001
24h diastolic BP (mmHg) 79 ± 8 78 ± 8 82 ± 8 < 0.001
24h heart rate (beats/min) 75 ± 9 76 ± 9 73 ± 9 0.002
Hypertension (%) 63.6 59.1 70.4 0.015
Serum triglycerides (mmol/L) 1.4 ± 0.83 1.3 ± 0.7 1.7 ± 0.9 < 0.001
Serum cholesterol (mmol/L) 5.4 ± 1.0 5.5 ± 1.0 5.3 ± 1.0 0.101
Serum HDL-cholesterol (mmol/L) 1.3 ± 0.3 1.4 ± 0.3 1.2 ± 0.3 < 0.001
Serum LDL-cholesterol (mmol/L) 3.6 ± 0.9 3.6 ± 0.9 3.7 ± 1.0 0.587
Metabolic syndrome (%) 46.9 45.9 48.4 0.594
Table 2  Echocardiographic findings in the total study population and in groups of women and men
LV left ventricular, GLS global longitudinal strain
Variable Total study population 
(n = 493)
Women (n = 301) Men (n = 192) P
LV end-diastolic diameter (cm) 4.95 ± 0.47 4.83 ± 0.42 5.15 ± 0.45 < 0.001
LV end-systolic diameter (cm) 3.27 ± 0.40 3.18 ± 0.36 3.41 ± 0.42 < 0.001
Interventricular septal thickness in diastole (cm) 1.09 ± 0.23 1.01 ± 0.18 1.21 ± 0.24 < 0.001
Posterior wall thickness in diastole (cm) 0.83 ± 0.16 0.79 ± 0.14 0.91 ± 0.16 < 0.001
LV mass index (g/m2.7) 39.2 ± 8.9 37.3 ± 7.7 42.0 ± 9.9 < 0.001
Relative wall thickness 0.34 ± 0.08 0.33 ± 0.07 0.36 ± 0.08 < 0.001
LV hypertrophy (%) 15.2 12.1 20.0 0.018
Ejection fraction 62 ± 5 62 ± 5 62 ± 5 0.318
GLS (%) − 19.4 ± 3.0 − 19.9 ± 3.0 − 18.6 ± 3.0 < 0.001
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However, a stronger influence of abdominal obesity on 
LV mass in women than men was demonstrated in the 
community-based Strong Heart Study which included a 
high proportion of subjects with obesity and type 2 dia-
betes [12]. Further, in treated hypertensive subjects fol-
lowed in the Campania Salute Network project, obesity 
was identified as a more powerful risk factor for incident 
LV hypertrophy in women than men [31]. In our study 
LV GLS was higher in women than in men, independent 
of LV EF, in line with previous findings in community-
based and hypertensive cohorts [13, 14, 32]. Interestingly, 
women had higher LV GLS despite the higher prevalence 
of abdominal obesity, reflected by increased waist circum-
ference, in women compared to men. Furthermore, higher 
arterial stiffness, measured by carotid-femoral PWV, 
remained significantly associated with lower LV GLS after 
adjustment for confounders only in women, despite the 
higher PWV in men. Bell et al. demonstrated in the much 
larger Framingham Offspring and Omni study that higher 
PWV was associated with lower LV GLS in both women 
and men, while higher characteristic impedance was asso-
ciated with lower LV GLS only in women [32]. Taken 
together, it may be suggested that LV long-axis function 
in women may be particularly sensitive to mechanical cou-
pling in the proximal aorta. Of note, the 2495 participants 
in the Framingham Offspring and Omni study were on 
average 20 years older than the present study cohort and 
non-obese [32]. Thus, the present results expand previous 
findings to middle-aged women with increased BMI.
In the present study, HOMA-IR, a marker of insulin sen-
sitivity, was particularly associated with lower LV GLS in 
men, independent of abdominal obesity. The observation 
Table 3  Covariables of lower GLS in uni- and multivariable linear regression in the total study population and in women and men
HOMA-IR homeostatic model of insulin resistance
Variables Total study population (n = 493) Women (n = 301) Men (n = 192)
Univariable Multivariable Univariable Multivariable Univariable Multivariable
β p β p β p β p β p β p
Male sex 0.21 < 0.001 0.13 0.005
Waist circumference (cm) 0.26 < 0.001 0.18 < 0.001 0.17 0.003 0.12 0.041 0.35 < 0.001 0.30 < 0.001
HOMA-IR 0.21 < 0.001 0.16 < 0.001 0.13 < 0.028 0.07 0.226 0.28 < 0.001 0.24 0.001
Serum triglycerides (mmol/L) 0.13 0.004 0.07 0.155 0.15 0.010 0.11 0.063 0.03 0.659 0.02 0.879
Pulse wave velocity (m/s) 0.18 < 0.001 0.13 0.004 0.18 0.002 0.18 0.003 0.11 0.117 0.02 0.744
Hypertension 0.16 < 0.001 0.04 0.359 0.14 0.016 0.05 0.456 0.11 0.130 0.04 0.559
Ejection fraction (%) − 0.21 < 0.001 − 0.21 < 0.001 − 0.19 0.001 − 0.21 < 0.001 − 0.22 0.003 − 0.22 0.002
Figure 1  The association of myocardial function assessed by LV GLS with serum triglycerides (a) and C-peptide (b) in women and men
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adds to a previous report by Blomstrand et al. indicating a 
progressive reduction in LV GLS with increasing BMI in 
participants with type 2 diabetes [33]. However, sex-spe-
cific results were not provided in their report. In women, an 
association of higher serum TG, an important component 
of atherogenic dyslipidemia, with reduced LV GLS was 
found in univariable analysis, while no such correlation was 
identified in men. However, this association was attenuated 
when adjusted for HOMA-IR. A possible explanation for 
these diverging findings may be the higher estrogen level in 
women, which has been shown to decrease glucose oxida-
tion, protect from insulin resistance and increase fatty acid 
oxidation in liver and skeletal muscles [34, 35]. Further-
more, Peterson et al. demonstrated in studies of myocardial 
metabolism using positron emission tomography that obesity 
was associated with increased myocardial oxygen demand 
and myocardial fatty acid metabolism [36], and that the 
influence of obesity on myocardial glucose metabolism was 
more pronounced in men than women [37]. Furthermore, in 
a study of healthy volunteers, Ng et al. found an association 
between increased epicardial adipose tissue, more extensive 
adipose infiltration in LV myocardium and reduced LV GLS 
[11]. From this it may be hypothesized that sex differences 
in epicardial and myocardial fat content may contribute to 
the observed sex difference in myocardial function found 
by LV GLS in the present study. However, neither computer 
tomography, nor positron emission tomography of the heart 
was performed in the FATCOR study.
4.1  Study Limitations
Due to the cross-sectional study design causality between 
LV GLS and the identified covariates cannot be claimed. The 
study participants were mostly recruited through an adver-
tisement in the local newspaper, which may have caused 
some selection bias. Furthermore, in this cross-sectional 
study the duration of increased BMI and hypertension in 
the individual participant is unknown. Measurements of sex 
hormones and information regarding menopause-status were 
not included in our study.
5  Conclusion
In subjects with increased BMI without known cardiac dis-
ease participating in the FATCOR study, women had better 
myocardial function assessed by LV GLS compared to men, 
despite more pronounced visceral obesity. Lower LV GLS 
was associated with increased abdominal obesity and LV 
EF in both sexes, and particularly with arterial stiffness in 
women, and with insulin resistance in men.
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